These Analysts Cut Their Forecasts On Elevance Health Following Q3 Earnings - Elevance Health ( NYSE:ELV )
Elevance Health Inc. ELV reported weaker-than-expected earnings for its third quarter on Thursday. The company posted revenues of $44.7 billion, up 5.3% year-over-year, beating the consensus of $43.33 billion. Profit fell 21% to $1.02 billion, or $4.36 a share.
| Ticker |
Sentiment |
Impact |
|
BX
|
Neutral
|
12 %
|
|
ELV
|
Neutral
|
73 %
|
